CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
STARR (Stapled Trans Anal Rectal Resection) +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04892108
NCT04892108N/ACompleted
CompareCT.gov

Surgical Treatment of Internal Rectal Prolapse Associated With Obstructed Defecation: Transanal Prolassectomy Versus Laparoscopic Ventral Rectopexy. Randomized Controlled Trial.

University Hospital of Ferrara·interventional·Posted May 19, 2021·Updated May 28, 2021

In Brief

A clinical study evaluating STARR (Stapled Trans Anal Rectal Resection) and LVR (Laparoscopic Ventral Rectopexy) for Rectal Prolapse and 3 related conditions. Completed, enrolled 70 participants across 1 site.

Detailed Summary

The objective of the study will be to evaluate the clinical and functional outcome of patients with obstructed defecation sndrome (ODS) associated to internal rectal prolapse, treated with transanal prolassectomy (STARR) surgery compared to those treated with laparoscopic ventral rectopexy (LVR).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRectal Prolapse, Defecation Disorder, Rectocele; Female, Surgery
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 19, 2021
Enrollment StartJan 1, 2017
Primary CompletionJan 1, 2019
Study CompletionMar 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 5.1 years ago

Interventions

STARR (Stapled Trans Anal Rectal Resection)procedure

Patients randomly assigned to surgical intervention of STARR (Stapled Trans Anal Rectal Resection)

LVR (Laparoscopic Ventral Rectopexy)procedure

Patients randomly assigned to surgical intervention of LVR (Laparoscopic Ventral Rectopexy)